Incidence of Programmed Cell Death 1 Inhibitor-Related Pneumonitis in Patients With Advanced Cancer: A Systematic Review and Meta-analysis - Nishino, Mizuki; Giobbie-Hurder, Anita; Hatabu, Hiroto; Ramaiya, Nikhil H; Hodi, F Stephen (JAMA oncology, 2016)
Keywords: Antibodies, Monoclonal - adverse effects; Antibodies, Monoclonal, Humanized - adverse effects; Antineoplastic Agents - adverse effects; Carcinoma, Non-Small-Cell Lung - complications; Carcinoma, Non-Small-Cell Lung - drug therapy; Carcinoma, Non-Small-Cell Lung - pathology; Carcinoma, Renal Cell - complications; Carcinoma, Renal Cell - drug therapy; Carcinoma, Renal Cell - pathology; Disease-Free Survival; Humans; Melanoma - complications; Melanoma - drug therapy; Melanoma - pathology; Nivolumab; Pneumonia - chemically induced; Pneumonia - genetics; Pneumonia - pathology; Programmed Cell Death 1 Receptor - antagonists & inhibitors; Programmed Cell Death 1 Receptor - genetics; Treatment Outcome